If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
36.25    3.25 (9.85%)
Bid:
35.85
Ask:
36.60
Spread: 0.75 (2.092%)
Market Cap: £241.37m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Fourth Quarter Trading Update

26 Jan 2026 07:00

RNS Number : 2546Q
S4 Capital PLC
26 January 2026
 

S4 Capital PLC

26 January 2026

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 on market abuse ("UK MAR"), as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. 

 

 

S4 Capital plc

Fourth Quarter Trading Update

("S4 Capital", "the Company" or "the Group")

 

2025 full year ahead of revised guidance and current consensus

Liquidity and net debt significantly improved and leverage expected to be 1.1x operational EBITDA

Final dividend of 1p subject to Board and Shareowner approval

 

 

S4 Capital plc (SFOR.L) confirms that 2025 full year trading was ahead of the revised guidance issued on the 24 November 2025 and is above the current consensus of net revenue of £664 million and operational EBITDA of £75 million. The Company expects like-for-like net revenue to be down circa 8.5%, with an operational EBITDA margin of circa 12%.

 

Net debt will be both significantly below current consensus of £133 million and below the previously indicated range of £100-140 million, following a change in Treasury management and a consequent strong focus on working capital management resulting in an improvement in liquidity.

 

The net debt to operational EBITDA ratio at the end of 2025 is expected to be approximately 1.1x versus current consensus of 1.8x and well below the target of 1.5x.

 

The annual results for 2025 will be announced on 25 March 2026 at which point the Company will provide more detailed targets for 2026.

 

The Company will recommend a 1p dividend, subject to the finalisation of the annual results and approval from the Board and Shareowners.

 

 

Sir Martin Sorrell, Executive Chairman of S4Capital plc said:

 

"Good to see both delivery beyond revised net revenue and operational EBITDA guidance and the significant improvement in liquidity. However, there is still much more to be done around net revenue and margin growth in 2026 and beyond which we will cover with the 2025 results presentation in March. The recommended 1p final dividend is an indication of the Board's confidence in continued improvement. In an increasingly volatile world, clients continue to carefully assess where they should expand geographically and how they can apply new technologies such as AI, Blockchain and Quantum to increasing efficiency."

 

 

Enquiries to:

S4Capital plc

+44 (0)20 3793 0003

Sir Martin Sorrell (Executive Chairman)

 

 

About S4Capital

 

Our strategy is to build a purely digital advertising and marketing services business for global, multinational, regional, and local clients, and millennial-driven influencer brands. We now have two synchronised practices: Marketing services and Technology services, along with an emphasis on 'faster, better, cheaper, more' execution in an always-on consumer-led environment, with a unitary structure.

The Company now has approximately 6,300 people in 33 countries with approximately 80% of net revenue across the Americas, 15% across Europe, the Middle East and Africa and 5% across Asia-Pacific. The longer-term objective is a geographic split of 60%:20%:20%.

 

Sir Martin was CEO of WPP for 33 years, building it from a £1 million 'shell' company in 1985 into the world's largest advertising and marketing services company, with a market capitalisation of over £16 billion on the day he left. Prior to that Sir Martin was Group Financial Director of Saatchi & Saatchi Company Plc for nine years.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEIFWIEMSELF
Date   Source Headline
20th Jul 20203:29 pmRNSDirector/PDMR Shareholding
17th Jul 20207:00 amRNSIssue of Shares
16th Jul 20207:11 amRNSResults of Fundraising
15th Jul 20205:09 pmRNSProposed Fundraising
15th Jul 20205:05 pmRNSTrading Update
13th Jul 20207:00 amRNSNotice of Results and Capital Markets Day
6th Jul 202010:53 amRNSHolding(s) in Company
6th Jul 202010:51 amRNSHolding(s) in Company
30th Jun 20207:00 amRNSTransaction and Board Appointment
30th Jun 20207:00 amRNSTotal voting rights and Block Listing 6m Return
24th Jun 20208:00 amRNSIssue of Shares
11th Jun 20207:00 amRNSIssue of Shares
8th Jun 20205:41 pmRNSResults of Annual General Meeting
8th Jun 20207:00 amRNSAGM Statement
29th May 202010:21 amRNSTotal Voting Rights
26th May 20207:00 amRNSDigodat to merge with MightyHive
19th May 20207:00 amRNSIssue of Shares
15th May 20203:13 pmRNSPosting of Annual Report and Notice of AGM
7th May 20207:00 amRNSFirst Quarter Trading Update
30th Apr 202011:03 amRNSTotal Voting Rights
24th Apr 20207:00 amRNSIssue of Shares
16th Apr 20207:00 amRNSIssue of Shares
7th Apr 202011:45 amRNSDirector/PDMR Shareholding
31st Mar 202011:51 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSDirector/PDMR Shareholding
24th Mar 20204:43 pmRNSSecond Price Monitoring Extn
24th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSFinal Results
12th Mar 202012:37 pmRNSIssue of Shares
28th Feb 20209:25 amRNSTotal Voting Rights
31st Jan 20207:00 amRNSTotal Voting Rights
8th Jan 20207:00 amRNSAnnouncement of merger and trading statement
31st Dec 20197:00 amRNSTotal Voting Rights
30th Dec 20197:00 amRNSIssue of Shares
10th Dec 20197:00 amRNSAppointment of two Non-Executive Directors
10th Dec 20197:00 amRNSIssue of Shares
5th Dec 20197:00 amRNSHolding(s) in Company
4th Dec 20197:00 amRNSHolding(s) in Company
29th Nov 20197:00 amRNSTotal Voting Rights
20th Nov 20199:30 amRNSTransaction
4th Nov 20197:00 amRNSThird Quarter Trading Update
31st Oct 20197:00 amRNSTotal Voting Rights
29th Oct 20197:00 amRNSIssue of Shares
28th Oct 20197:00 amRNSTransactions
25th Oct 20191:50 pmRNSDirector/PDMR Shareholding
25th Oct 20197:00 amRNSAdmission to Trading on the London Stock Exchange
24th Oct 201911:44 amRNSResults of General Meeting
23rd Oct 201912:30 pmRNSReplacement: Result of Open Offer Announcement
23rd Oct 20197:00 amRNSResult of Open Offer Announcement
8th Oct 201911:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.